Alexander Cole
Company: Alexion Pharmaceuticals
Job title: Executive Director & Head of Epidemiology & Real-World Science
Seminars:
9:25 Chair’s Opening Remarks 9:00 am
day: Day 2 full
4:30 Chair’s Closing Remarks 4:30 pm
day: Day 2 full
Real-World Evidence in Clinical Research 10:30 am
day: Day 1 AM pt1
9:30 Leveraging Artificial Intelligence & Machine Learning for Patient Identification in Rare Disease Research 9:30 am
Utilize AI-driven algorithms to analyze diverse data sources, improving the identification of rare disease patients and reducing diagnostic delays Apply machine learning models to uncover hidden patterns in RWD, enhancing early detection and recruitment for clinical trials Ensure regulatory and ethical compliance in AI-based patient identification by addressing biases, data privacy concerns, and transparency in model validationRead more
day: Day 1 AM
9:00 Strategies to Streamline Collaboration, Accelerate Decision Making & Improve Real-World Evidence Acceptance Across Pharma, Regulators & Payers 9:00 am
Navigating payer and regulatory requirements in RWE is a high-stakes challenge, one missed step can mean delays, denied coverage, or wasted data. Regulators demand rigor, payers prioritize cost-effectiveness, yet their definitions of “acceptable evidence” rarely align. With evolving guidelines and increasing scrutiny, how can pharma generate the right data to bridge this gap? Unpack real-world case studies on…Read more
day: Pre-Conference Payers & Regulatory Alignment Day